Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 32, Issue 2, 2001, Pages 171-177

  Bunn, Susan K ^a   Bisset, W Michael ^b   Main, Margaret J C ^a   Golden, Barbara E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROYAL ABERDEEN CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Calprotectin; Child; Crohn disease; Disease activity; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ALBUMIN; CALPROTECTIN;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CALCULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE SEVERITY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FECES ANALYSIS; FECES LEVEL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; INFANT; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MEMBRANE GLYCOPROTEINS; NEURAL CELL ADHESION MOLECULES; SEVERITY OF ILLNESS INDEX;

EID: 0035065788     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200102000-00015     Document Type: Article

References (33)

1. Laboratory assessment of inflammatory bowel disease
2. Assessment of disease severity and activity in inflammatory bowel disease
3. Assessment of inflammatory activity in Crohn's disease
4. A clinical scoring system for chronic inflammatory bowel disease in children
5. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen
6. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin
7. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin
8. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence
9. Inhibition of Candida albicans growth by calprotectin in the absence of direct contact with the organisms
10. Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease
11. The myeloic related protein MRP8/14 (27E10 antigen)-usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function
12. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study
13. Faecal calprotectin: A novel test for the diagnosis of colorectal cancer?
14. Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs
15. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein
16. PMN-elastase in assessment of patients with inflammatory bowel disease
17. Circulating human leucocyte elastase in patients with inflammatory bowel disease
18. Protease inhibitors in plasma and faecal extracts from patients with active inflammatory bowel disease
19. Semiquantitative determination of fecal leukocyte esterase by a dip-and-read assay
20. Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease
21. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation
22. Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea
23. PAF-acether and acetyl-hydrolase in stool of patients with Crohn's disease
24. Increased fecal eosinophil cationic protein in inflammatory bowel disease
25. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls
26. Faecal alpha-lantitrypsin and excretion of 111 indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases
27. Granulopoiesis, senescence and random loss of neutrophilic granulocytes in human beings
28. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion
29. Clinical disease activity and inflammatory activity in the rectum in relation to mucosal inflammation assessed by colonoscopy. A study of children and adolescents with chronic inflammatory bowel disease
30. Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis
31. Laboratory markers of colonoscopic activity in ulcerative colitis and Crohn colitis
32. Clinical remission in Crohn's disease-assessment using fecal 111 in granulocyte excretion
33. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study